Trailing-twelve-month (TTM) revenue is $2.45 Billion with a year-over-year growth of +14.70%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q2 FY2026Period ended 2025-09-30 | $608,826,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-06 |
| Q3 FY2026Period ended 2025-12-31 | $614,774,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-04 |
| Q4 FY2026Period ended 2026-03-31 | $581,634,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-28 |
| Q1 FY2027Period ended 2026-06-30 | $649,113,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-04 |
| TTM revenue | $2,454,347,000 |
Current P/S: $2,442,655,377 market capitalization ÷ $2,454,347,000 TTM revenue = 1.00x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T18:00:01.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q1 FY2027 (2026-06-30): $649.11M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T18:04:53.357Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2026-03-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2026-03-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20212021-03-31 · USD | FY20222022-03-31 · USD | FY20232023-03-31 · USD | FY20242024-03-31 · USD | FY20252025-03-31 · USD | FY20262026-03-31 · USD |
|---|---|---|---|---|---|---|
| Financing Reporting Unit | $12M | $35M | $9M | $6M | N/A | N/A |
| Product | N/A | N/A |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20132013-03-31 · USD | FY20252025-03-31 · USD | FY20262026-03-31 · USD |
|---|---|---|---|
| Foreign Country 1 | $18M | N/A | N/A |
| Non-US | N/A | $85M | $93M |
| UNITED STATES | $965M | $2.0B | $2.3B |
$2.45B
$2.45 Billion
+14.70%
vs. $2.14B a year ago (TTM)
+8.53%
5 Year compound annual growth rate
1 Year
+14.70%
3 Year
+3.97%
5 Year
+8.53%
10 Year
+7.13%
15 Year
+6.88%
20 Year
+6.57%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2026 | $2.44B | +$373.76M | +18.07% |
| 2025 | $2.07B | ($156.51M) | (7.03%) |
| 2024 | $2.23B | +$157.58M | +7.62% |
| 2023 | $2.07B | +$246.70M | +13.55% |
| 2022 | $1.82B | +$252.70M | +16.11% |
| 2021 |
TTM Growth
+14.70%
3-Year CAGR
+3.97%
5-Year CAGR
+8.53%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-10-06T18:04:53.357Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| N/A |
| $1.7B |
| $2.0B |
| Service | N/A | N/A | N/A | N/A | $400M | $463M |
|---|
| Technology Reporting Unit | $1.5B | $1.7B | N/A | $2.2B | N/A | N/A |
|---|
| $1.57B |
| ($20.08M) |
| (1.26%) |
| 2020 | $1.59B | +$215.73M | +15.72% |
| 2019 | $1.37B | ($46.13M) | (3.25%) |
| 2018 | $1.42B | +$89.41M | +6.73% |
| 2017 | $1.33B | +$125.19M | +10.40% |
